Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev

The firm’s partnership with industrial family investors, led by the Mulliez family investment arm, will accelerate growth and fuel the development of technology and solutions-enabled services.

News
Published on:
April 12, 2021

FRAMINGHAM, Mass. – April 12, 2021 – Alira Health (www.alirahealth.com), a leading international advisory firm dedicated to advancing healthcare and life sciences , announced it has closed a $35M equity financing led by Creadev, an evergreen investment company backed by the Mulliez family. This new partnership will help accelerate the firm’s growth strategy, focused on merging pharmaceutical, medical and digital technologies development with medical care through a patient-centric approach.

“I would like to thank our team of investors for joining our mission to enable healthcare transformation. Their investment positions us to change the way life sciences advisory services are delivered,” said Gabriele Brambilla, Chief Executive Officer and Co-Founder of Alira Health. “We are building a powerful continuum of services that spans the product and solutions development life cycle, supported by the recent additions of our patient engagement, real-world evidence and advanced analytics practices. This financing allows us to advance the science and strategy of healthcare with our clients, ultimately enhancing patient outcomes.”

Gabriele Brambilla

“We were looking for investors who would recognize the value of our mission, bring new perspectives to our approach, and partner with us for a long-term, ambitious plan of innovative and global growth. We are honored that Creadev, together with two other life sciences industrial families, chose to join Alira Health and support our leadership and vision“ said Benjamin Chambon, Chief Commercial Officer and Co-Founder of Alira Health.

 

“The Creadev team is proud to partner with Alira Health,” said Yohann Gbahoué, Executive Director, Creadev. “Alira Health’s approach to healthcare advisory is pioneering, and we see the impact of their work on patient outcomes growing as the company continues to implement their strategic vision. We join the entire investment team in congratulating Gabriele and the firm and look forward to supporting their future growth.”

The group of new investors will hold a minority interest in Alira Health. This operation empowers the company to accelerate the development of their technology-enabled services and boost the firm’s inorganic growth strategy in the U.S. and EU.

Advisors to Creadev: Finance & Tax (Alvarez & Marsal), Legal (King & Spalding), IT/Data (Z Consulting), HR (Selescope)

Advisors to Alira Health: Equiteq represented Alira Health in the transaction

About Creadev:
Creadev is an evergreen investment firm operating worldwide, controlled by the Mulliez family, founders of one of the largest Business to Consumer retail platforms in the world. Creadev is committed to long-term collaboration with innovative, passionate, and human-driven entrepreneurs that are focused on creating widespread access to essential goods and services such as healthcare, sustainable consumption and food. Based in Paris, and with offices in New-York, Shanghai and Nairobi, Creadev invests in companies well positioned to scale and become worldwide leaders in their respective sectors. Launched in 2002, Creadev has invested over €1.8 Bn in companies in stages ranging from venture to growth equity and buyout.

Read the press release on BusinessWire here.

Related news

MedTech
News July 22, 2021
Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head
We are pleased to announce that Fredrik Nyberg has joined Alira Health as Partner and Regional Head
Due Diligence Pharma
News July 21, 2021
Alira Health Announces its Role as Strategic Advisor to Naxicap
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
MedTech
Events July 15, 2021
Event: Cardio Wearables 2021 Conference
Join Piergiulio Lauriano for an exclusive discussion on Cardio Wearables Investments and M&A Trends during the conference.
MedTech Pharma
Events June 30, 2021
Event: Bio Asia-Taiwan
Join Daniela Sica, Vice President, Business Development, Pharma & Biotech, and Shu-Ling Cheng, Partner, at Biotechnology Innovation Organization's Bio-Asia Taiwan July 21-25, 2021.
MedTech
Publications June 2, 2021
Infographic: U.S. Go-to- Market Strategy Design for Wearable Technology in Healthcare
When our client, a European healthcare-based startup developing wrist wearables wanted to expand to the U.S., the Alira Health team helped develop a go-to-market strategy for this new segment.
MedTech
Publications May 14, 2021
Pocket Guide To MedTech’s Market Outlook In 2021
In this article Carlo unveils findings and summaries from The 2021 MedTech Contract Manufacturing Report, recently published by Alira Health in collaboration with Life Science Intelligence(...)
MedTech
Publications May 7, 2021
Robotic Surgery Report Pre-download
Want to learn more about key topics and trends across robotic surgery and commercial considerations? Be the first to have access to our upcoming report on Robotics, written by Alira(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.